Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Targeting the IL-17 pathway in infla...
~
SpringerLink (Online service)
Targeting the IL-17 pathway in inflammatory disorders
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Targeting the IL-17 pathway in inflammatory disorders/ by Cong-Qiu Chu.
Author:
Chu, Cong-Qiu.
Published:
Cham :Springer International Publishing : : 2017.,
Description:
xv, 102 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
Subject:
Interleukins. -
Online resource:
http://dx.doi.org/10.1007/978-3-319-28040-0
ISBN:
9783319280400
Targeting the IL-17 pathway in inflammatory disorders
Chu, Cong-Qiu.
Targeting the IL-17 pathway in inflammatory disorders
[electronic resource] /by Cong-Qiu Chu. - Cham :Springer International Publishing :2017. - xv, 102 p. :ill., digital ;24 cm.
This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
ISBN: 9783319280400
Standard No.: 10.1007/978-3-319-28040-0doiSubjects--Topical Terms:
1028088
Interleukins.
LC Class. No.: QR185.8.I56
Dewey Class. No.: 571.96
Targeting the IL-17 pathway in inflammatory disorders
LDR
:01685nam a2200301 a 4500
001
957366
003
DE-He213
005
20161128200532.0
006
m d
007
cr nn 008maaau
008
201118s2017 gw s 0 eng d
020
$a
9783319280400
$q
(electronic bk.)
020
$a
9783319280394
$q
(paper)
024
7
$a
10.1007/978-3-319-28040-0
$2
doi
035
$a
978-3-319-28040-0
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QR185.8.I56
072
7
$a
MJM
$2
bicssc
072
7
$a
MED083000
$2
bisacsh
082
0 4
$a
571.96
$2
23
090
$a
QR185.8.I56
$b
C559 2017
100
1
$a
Chu, Cong-Qiu.
$3
1248919
245
1 0
$a
Targeting the IL-17 pathway in inflammatory disorders
$h
[electronic resource] /
$c
by Cong-Qiu Chu.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Adis,
$c
2017.
300
$a
xv, 102 p. :
$b
ill., digital ;
$c
24 cm.
520
$a
This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
650
0
$a
Interleukins.
$3
1028088
650
0
$a
Inflammation.
$3
583465
650
1 4
$a
Medicine & Public Health.
$3
593949
650
2 4
$a
Rheumatology.
$3
668542
650
2 4
$a
Dermatology.
$3
669082
650
2 4
$a
Pharmacotherapy.
$3
973587
650
2 4
$a
Primary Care Medicine.
$3
673694
650
2 4
$a
Public Health.
$3
592982
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-28040-0
950
$a
Medicine (Springer-11650)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login